World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
69
Citations
17730
World Ranking
6161
National Ranking
204

Alain Beck publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Alain Beck sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 218 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Alain Beck D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Alain Beck sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 69 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Alain Beck is affiliated with the University of Strasbourg in France and has contributed extensively to the fields of biochemistry, medicine, and chemistry. Their research spans 36 publications in biochemistry, genetics, and molecular biology, 35 in medicine, and 23 in chemistry. Within these fields, their focus includes molecular biology, radiology, nuclear medicine and imaging, spectroscopy, oncology, and biomedical engineering.

Their main research topics cover protein purification and stability, with 52 publications in this area, and monoclonal and polyclonal antibodies research, comprising 46 publications. They have also worked on analytical chemistry and chromatography, mass spectrometry techniques and applications, viral infectious diseases and gene expression in insects, microfluidic and capillary electrophoresis applications, and HER2/EGFR in cancer research.

Beck has published in a range of journals, frequently appearing in Analytical Chemistry (6 publications), Journal of Pharmaceutical and Biomedical Analysis (4 publications), Journal of Chromatography A (4 publications), Pharmaceuticals (2 publications), and Journal of the American Society for Mass Spectrometry (2 publications).

Their recent significant papers include:

  • Antibody-drug conjugates come of age in oncology, 2023, Nature Reviews Drug Discovery
  • Antibody-Drug Conjugates: The Last Decade, 2020, Pharmaceuticals
  • Therapeutic Fc-fusion proteins: Current analytical strategies, 2020, Journal of Separation Science
  • Interlaboratory Study for Characterizing Monoclonal Antibodies by Top-Down and Middle-Down Mass Spectrometry, 2020, Journal of the American Society for Mass Spectrometry
  • Combination of intact, middle-up and bottom-up levels to characterize 7 therapeutic monoclonal antibodies by capillary electrophoresis - Mass spectrometry, 2020, Journal of Pharmaceutical and Biomedical Analysis

Frequent co-authors in their publications include Davy Guillarme (18 collaborations), Sarah Cianférani (13 collaborations), Valentina D'Atri (11 collaborations), Szabolcs Fekete (9 collaborations), and Olivier Colas (8 collaborations).

Best Publications

  • Strategies and challenges for the next generation of antibody–drug conjugates

    Alain Beck;Liliane Goetsch;Charles Dumontet;Nathalie Corvaïa

  • Strategies and challenges for the next generation of therapeutic antibodies

    Alain Beck;Thierry Wurch;Christian Bailly;Nathalie Corvaia

  • Antibody–drug conjugates come of age in oncology

    Unknown

  • Characterization of Therapeutic Antibodies and Related Products

    Alain Beck;Elsa Wagner-Rousset;Daniel Ayoub;Alain Van Dorsselaer

  • Theory and practice of size exclusion chromatography for the analysis of protein aggregates.

    Szabolcs Fekete;Alain Beck;Jean-Luc Veuthey;Davy Guillarme

  • Antibody-Drug Conjugates: The Last Decade.

    Nicolas Joubert;Alain Beck;Charles Dumontet;Caroline Denevault-Sabourin

  • A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor receptor therapy against human cancer xenografts

    Liliane Goetsch;Alexandra Gonzalez;Olivier Leger;Alain Beck

  • Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins.

    Alain Beck;Elsa Wagner-Rousset;Marie-Claire Bussat;Maryline Lokteff

  • Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry

    Alain Beck;Sarah Sanglier-Cianférani;Alain Van Dorsselaer

  • Ion-exchange chromatography for the characterization of biopharmaceuticals

    Szabolcs Fekete;Alain Beck;Jean-Luc Veuthey;Davy Guillarme

  • Structure, heterogeneity and developability assessment of therapeutic antibodies

    Yingda Xu;Dongdong Wang;Bruce Mason;Tony Rossomando

  • Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody.

    Josef Vlasak;Marie C. Bussat;Shiyi Wang;Elsa Wagner-Rousset

  • Forced degradation of recombinant monoclonal antibodies: A practical guide.

    Christine Nowak;Jason K. Cheung;Shara M. Dellatore;Amit Katiyar

  • Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies.

    Alexandre Goyon;Melissa Excoffier;Marie Claire Janin-Bussat;Balazs Bobaly

  • Marketing approval of mogamulizumab: A triumph for glyco-engineering

    Alain Beck;Janice M. Reichert

  • Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part II: pH gradient approach

    Szabolcs Fekete;Alain Beck;Jenő Fekete;Davy Guillarme

  • Middle-Down Analysis of Monoclonal Antibodies with Electron Transfer Dissociation Orbitrap Fourier Transform Mass Spectrometry

    Luca Fornelli;Daniel Ayoub;Konstantin Aizikov;Alain Beck

  • Innovative Native MS Methodologies for Antibody Drug Conjugate Characterization: High Resolution Native MS and IM-MS for Average DAR and DAR Distribution Assessment

    François Debaene;François Debaene;Amandine Bœuf;Elsa Wagner-Rousset;Olivier Colas

  • Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies.

    Alain Beck;Janice M Reichert

  • The next generation of antibody-drug conjugates comes of age.

    Alain Beck;Jean-François Haeuw;Thierry Wurch;Liliane Goetsch

  • Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques.

    Daniel Ayoub;Wolfgang Jabs;Anja Resemann;Waltraud Evers

  • Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells

    Alain Beck;Marie-Claire Bussat;Nathalie Zorn;Virginie Robillard

  • Hydrophobic interaction chromatography for the characterization of monoclonal antibodies and related products

    Szabolcs Fekete;Jean-Luc Veuthey;Alain Beck;Davy Guillarme

  • Analytical characterization of biosimilar antibodies and Fc-fusion proteins

    Alain Beck;Hélène Diemer;Daniel Ayoub;François Debaene

  • Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine‐linked antibody drug conjugate

    Julien Marcoux;Julien Marcoux;Thierry Champion;Olivier Colas;Elsa Wagner-Rousset

  • Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies.

    Alain Beck;François Debaene;Hélène Diemer;Elsa Wagner-Rousset

  • Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion

    Elsa Wagner-Rousset;Marie-Claire Janin-Bussat;Olivier Colas;Melissa Excoffier

  • Development of Comprehensive Online Two-Dimensional Liquid Chromatography/Mass Spectrometry Using Hydrophilic Interaction and Reversed-Phase Separations for Rapid and Deep Profiling of Therapeutic Antibodies.

    Dwight R. Stoll;David C. Harmes;Gregory O. Staples;Oscar G. Potter

Frequent Co-Authors

Davy Guillarme
Davy Guillarme University of Geneva
Szabolcs Fekete
Szabolcs Fekete University of Geneva
Alain Van Dorsselaer
Alain Van Dorsselaer University of Strasbourg
Jean-Luc Veuthey
Jean-Luc Veuthey University of Geneva
Janice M. Reichert
Janice M. Reichert Tufts University
Jean-Yves Bonnefoy
Jean-Yves Bonnefoy Salto Therapeutics
Alexey Lugovskoy
Alexey Lugovskoy Biogen (United States)
Alexander Makarov
Alexander Makarov Thermo Fisher Scientific (Israel)
Pavel A. Pevzner
Pavel A. Pevzner University of California, San Diego
Frank Sobott
Frank Sobott University of Leeds

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various interdisciplinary career opportunities. For example, students interested in crime-solving can explore forensic career paths, where chemical analysis plays a crucial role in investigations.

For those considering a legal angle, online education offers accessible routes into fields like criminal justice. Understanding how much is criminal justice school helps prospective students plan their finances and choose programs wisely.

Many students start with an accredited online criminal justice associate degree to gain foundational knowledge before advancing to higher-level studies or specialized roles. This flexibility can complement a chemistry background when pursuing careers in law enforcement or regulatory agencies.

Additionally, pursuing a paralegal studies associate degree can provide essential legal expertise useful in patent law, environmental regulation, or pharmaceutical compliance, expanding career options beyond traditional chemistry roles.

Best Scientists Citing Alain Beck

Trending Scientists

Recently Published Articles